Description

Decahydro-6-[2-[3-Hydroxy-2,6-Dimethyl-6-(4-Methyl-3-Pentenyl)-1-Cyclohexen-1-Yl]Ethyl]-2,2,5A,7-Tetramethyl-1-Benzoxepine-3,7-Diol is a high-purity, complex diterpenoid compound with significant biological activity. This compound matters for its role as a key intermediate in the synthesis of advanced pharmaceutical actives and fine chemicals, offering a critical building block for research and development. It is primarily needed by R&D laboratories, pharmaceutical manufacturers, and fine chemical producers focused on developing novel therapeutic agents and high-value specialty chemicals.

Application

• Pharmaceutical Intermediate: A critical precursor in the synthesis of novel drug candidates, particularly in oncology and anti-inflammatory research.
• Biochemical Research: Used as a reference standard or probe compound in pharmacological and metabolic pathway studies.
• Fine Chemical Synthesis: Serves as a sophisticated chiral building block for constructing complex natural product analogs and specialty molecules.
• Cosmetic & Dermatological Actives: Potential application in the development of high-end skincare formulations targeting specific biological pathways.
• Agrochemical Research: Investigated for use in creating new, targeted plant growth regulators or protective agents.

Basic Information

Product Name	Decahydro-6-[2-[3-Hydroxy-2,6-Dimethyl-6-(4-Methyl-3-Pentenyl)-1-Cyclohexen-1-Yl]Ethyl]-2,2,5A,7-Tetramethyl-1-Benzoxepine-3,7-Diol
CAS No.	87978-31-2
Molecular Formula	C30H52O4
Molecular Weight	476.73 g/mol
Synonyms	6-[2-[3-Hydroxy-2,6-dimethyl-6-(4-methyl-3-pentenyl)-1-cyclohexen-1-yl]ethyl]decahydro-2,2,5a,7-tetramethyl-1-benzoxepine-3,7-diol; (1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a,5a,5b,8,8,11a-hexamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-9,10-diol (a stereoisomer descriptor); Diterpenoid Benzoxepine Diol; Aromatic Diterpene Derivative
EINECS	Contact for details

Quality Control

Our Decahydro-6-[2-[3-Hydroxy-2,6-Dimethyl-6-(4-Methyl-3-Pentenyl)-1-Cyclohexen-1-Yl]Ethyl]-2,2,5A,7-Tetramethyl-1-Benzoxepine-3,7-Diol is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets exacting research and pharmaceutical-grade standards. Comprehensive Certificates of Analysis (COA) detailing all specifications are provided to guarantee traceability and batch-to-batch consistency.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound may be hygroscopic; therefore, the container should be kept tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals (as Pb)	≤ 10 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.